Home > Formulary : Adult > Recent Decisions > 2013 >
Decisions 10th December 2013
Recent JFG Decisions
At the meeting on the 10th December 2013 the following decisions / changes to the formulary were agreed:
New Drug Requests
Approved
Midazolam and Lignocaine
- Approved for inclusion onto the formulary for intranasal administration for conscious sedation to enable dental treatment in adults when a titratable technique is not possible. UHB only
Lactulose
- Approved for inclusion onto the formulary for use as part of the Enhanced recovery Programme following colorectal resection, following insertion of colonic stent and post-surgery following minor anorectal surgery.
Dundee sunscreen
- Approved for inclusion onto the formulary as a sunscreen when visible light range causes photodamage in paediatric patients. UHB only
Temocillin
- Approved for inclusion onto the formulary for the treatment of sepsis/UTIs/Respiratory tract infections that are caused by susceptible gram negative bacilli. TLS Red, UHB only, Restricted to Microbiology advice only.
Pending
Tamoxifen
- Approved for inclusion onto the formulary for the reduction in breast cancer incidence in people with a family history of breast, ovarian or related (prostate/pancreatic) cancer as recommended in NICE CG164, only after the patient has been identified, been appropriately counselled by and treatment recommended by the Bristol Breast Cancer Family History Service.
- This will be added to the formulary when the pathway for this cohort of patients has been agreed.
Ultibro®
- Approved for inclusion onto the formulary as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.
- This will be added to the formulary when Ultibo becomes available for prescription - this is expected in Spring 2014.
Rejected
none
Deferred
none
Specialised Commissioning
none
Shared Care Protocols
Methotrexate in IBD
- NBT and Weston
- new SCP
Aripiprazole
- AWP
- updated SCP and agreement form
Atypical Antipsychotic depots
- AWP
- amber 1 month
- new SCP and agreement form
Denosumab
- NBT/UHB/Weston
- amber
- updated SCP to include men
Change in TLS
Ranolazine
- proposal to change in TLS status from red to amber 3 months provisionally agreed - await SCP to be signed off before this change is implemented.